top of page

Commercialization Symposium on

Entrepreneurship, Therapeutic Discovery and Technological Development

Dec 8, 2023, 9:00am – 12:30pm followed by networking session 12:30-2:00pm
Charles K. Kao Auditorium, Hong Kong Science and Technology Park

Welcome to COI's inaugural Commercialization Symposium, where we will showcase the latest developments in therapeutic discovery and entrepreneurship from both local and international healthcare perspectives. Our engaging sessions will provide valuable insights into cutting-edge advancements in scientific research translation, intellectual property, and industrial partnerships, all through the eyes of our distinguished innovators and experts in the field. Join us for an enlightening experience that promises to make a lasting impact on the healthcare landscape.




Check-in and Welcome Reception


Welcome Remarks

Albert Wong, Chief Executive Officer, Hong Kong Science and Technology Parks Corporation

Keynote Presentation

Tak Mak, Ph.D. | A New Era of Immunology and Impact   

Flash Talks

Anskar Leung, M.D., Ph.D. | A cost effective strategy for high-throughput drug discovery - the zebrafish perspective
Alan Wong, Ph.D. | Perfecting CRISPR technology for applications
Naoto Hirano, M.D., Ph.D. | New generation of T cell-based immunotherapies
Alfred Tan, Ph.D. | Preparing research for better IP protection and successful commercialisation

Panel Discussion 1:

Life Science Entrepreneurship: A Scientist’s Perspective on Transforming Inventions into Innovations (Panel moderator: Dr. Steven Chan)
Anskar Leung, M.D., Ph.D. | Founder, ZeBlast Technology Ltd

Alan Wong, Ph.D. | Project Leader, Centre for Oncology and Immunology Ltd

Naoto Hirano, M.D., Ph.D. | Senior Scientist, University Health Network

Panel Discussion 2:

The Key Elements in the Path towards Commercialization: IP, Partnership, and Funding (Panel moderator: Prof. Anskar Leung)
Alfred Tan, Ph.D. | Deputy Director, Technology Transfer Office - The University of Hong Kong

Tony Cheng, EMBA | General Manager, Merck KGaA 

Karen Liu, EMBA, Ph.D. | Founding Partner, 3E Bioventures

Closing Remarks

Suet-Yi Leung, M.D. | Managing Director, Centre for Oncology and Immunology

Networking Session

Light refreshments will be provided.

Co-Organised By

Supported by

Diamond Sponsors

Platinum Sponsors

Gold Sponsor

Frame 380.png
Frame 386.png
Frame 389.png
Frame 381.png
Frame 385.png
Frame 382.png

© 2023 by Centre for Oncology and Immunology

bottom of page